Basel Medical Group (NASDAQ:BMGL) Announces Earnings Results

Basel Medical Group (NASDAQ:BMGL) released its earnings results on Friday. The company reported ($0.31) earnings per share for the quarter, reports. The company had revenue of $3.14 million for the quarter.

Basel Medical Group Stock Performance

Shares of NASDAQ:BMGL traded up $0.17 during mid-day trading on Friday, reaching $4.92. The stock had a trading volume of 1,706,133 shares, compared to its average volume of 286,667. Basel Medical Group has a twelve month low of $2.56 and a twelve month high of $18.72. The firm has a 50 day simple moving average of $4.37 and a two-hundred day simple moving average of $6.52.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, October 23rd. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.